Screener
Jasper Therapeutics, Inc. JSPR Q3 2025 earnings
Reported November 10, 2025 · Before market open
EPS-$1.13Miss by $0.12
EPS estimate-$1.01
Next report
Nov 9, 2026 (In 1 week)Revenue estimate$6.0M
EPS estimate-$0.06
Versus estimates
Diluted EPS
FAQ
- When did Jasper Therapeutics, Inc. report Q3 2025 earnings?
- Jasper Therapeutics, Inc. (JSPR) reported Q3 2025 earnings on November 10, 2025 before market open.
- What were Jasper Therapeutics, Inc.'s Q3 2025 revenue and EPS?
- Jasper Therapeutics, Inc. reported eps of $-1.13 for Q3 2025.
- Did Jasper Therapeutics, Inc. beat estimates in Q3 2025?
- EPS missed the consensus estimate of $-1.01 by $0.12.
- How did Jasper Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 8.9% from $-1.24.
- Where can I find Jasper Therapeutics, Inc.'s Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001213900-25-107874) and the 10-Q periodic report (0001213900-25-107884) directly on SEC EDGAR. The filing index links above go to sec.gov.
